David A. Siegel Ironwood Pharmaceuticals Inc Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,260,500 shares of IRWD stock, worth $4.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,260,500

Previous 1,199,000 5.13%

Holding current value

$4.35 Million

Previous $7.82 Million 33.73%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.93 - $7.04 $241,695 - $432,960	61,500 Added 5.13%	1,260,500 $5.18 Million
Q2 2024 Aug 14, 2024	SELL	$5.58 - $8.61 $479,880 - $740,460	-86,000 Reduced 6.69%	1,199,000 $7.82 Million
Q1 2024 May 15, 2024	SELL	$8.32 - $15.45 $472,576 - $877,560	-56,800 Reduced 4.23%	1,285,000 $11.2 Million
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $4.43 Million - $5.8 Million	-503,800 Reduced 27.3%	1,341,800 $15.4 Million
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $5.94 Million - $8.18 Million	-720,300 Reduced 28.07%	1,845,600 $17.8 Million
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $6.17 Million - $7.09 Million	611,000 Added 31.25%	2,565,900 $27.3 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $2.45 Million - $2.96 Million	236,000 Added 13.73%	1,954,900 $20.6 Million
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $11.9 Million - $14.9 Million	1,200,200 Added 231.39%	1,718,900 $21.3 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $1.25 Million - $1.52 Million	-122,900 Reduced 19.16%	518,700 $5.37 Million
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $847,535 - $975,624	-76,700 Reduced 10.68%	641,600 $7.4 Million
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $6.6 Million - $8.02 Million	622,500 Added 649.79%	718,300 $9.04 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $5.51 Million - $7.07 Million	-507,057 Reduced 84.11%	95,800 $1.12 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $5.76 Million - $6.72 Million	483,000 Added 402.98%	602,857 $7.87 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $3.39 Million - $4.38 Million	-334,000 Reduced 73.59%	119,857 $1.54 Million
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $1.62 Million - $2.12 Million	-179,000 Reduced 28.28%	453,857 $5.07 Million
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $932,150 - $1.26 Million	-103,000 Reduced 14.0%	632,857 $7.21 Million
Q3 2020 Nov 16, 2020	SELL	$8.99 - $10.74 $2.37 Million - $2.83 Million	-263,200 Reduced 26.34%	735,857 $6.62 Million
Q2 2020 Aug 14, 2020	SELL	$9.14 - $11.97 $1.47 Million - $1.92 Million	-160,400 Reduced 13.83%	999,057 $10.3 Million
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $1.54 Million - $2.51 Million	-179,000 Reduced 13.37%	1,159,457 $11.7 Million
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $8.37 Million - $14.3 Million	1,018,100 Added 317.8%	1,338,457 $17.8 Million
Q3 2019 Nov 14, 2019	SELL	$8.59 - $10.96 $4,295 - $5,480	-500 Reduced 0.16%	320,357 $2.75 Million
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $2.3 Million - $3.54 Million	277,700 Added 643.46%	320,857 $4.34 Million
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $62,400 - $129,039	8,000 Added 22.76%	43,157 $447,000
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $503,096 - $620,521	35,157 New	35,157 $649,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $529M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account